Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
229.7 USD | +2.07% |
|
-1.44% | -11.35% |
Jul. 16 | Biogen Needs Revenue-Generating Assets to Complete Turnaround, Wedbush Says | MT |
Jul. 16 | Redburn Atlantic Adjusts Price Target on Biogen to $230 From $235, Maintains Neutral Rating | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.35% | 32.76B | |
+7.46% | 100B | |
+11.97% | 42.34B | |
+79.34% | 29.46B | |
-12.26% | 16.31B | |
+3.73% | 14.39B | |
-1.90% | 12.23B | |
+178.17% | 10.47B | |
+1.80% | 8.97B | |
-54.74% | 8.84B |
- Stock Market
- Equities
- BIIB Stock
- News Biogen Inc.
- Transcript : Biogen Idec Inc., Q4 2014 Earnings Call, Jan 29, 2015